Eli Lilly and Company (LLY) Stock: Rises After FDA Approves Weekly Insulin Drug

TLDR Eli Lilly stock climbs after FDA approves weekly insulin drug Onswik Onswik offers a new weekly treatment option for type 2 diabetes patients FDA approval follows successful QWINT Phase 3 clinical trial results Lilly expands diabetes portfolio with innovative insulin technology Onswik receives fourth global approval after regulatory reviews worldwide Eli Lilly and Company [...]

The post Eli Lilly and Company (LLY) Stock: Rises After FDA Approves Weekly Insulin Drug appeared first on Blockonomi.